Exploring opportunities to improve the quality of life for those with Amyotrophic Lateral Sclerosis (ALS)
On December 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued explanations for the maximum fair prices (MFPs) for the drugs selected for the IRA’s Medicare Drug Price Negotiation Program for the initial price applicability year (IPAY) 2026.
The Academy of Managed Care Pharmacy (AMCP) thanks the Department of Health and Human Services, the Department of Labor, and the Department of the Treasure (collectively, the Departments) for the opportunity to provide comments in response to the proposed rule titled “Enhancing Coverage of Preventive Services Under the Affordable Care Act [CMS 9887–P]” published in the Federal Register on October 28, 2024.
AMCP CEO Susan Cantrell takes a moment to reflect on what AMCP has accomplished over the past year.
Pharmacy student Cayla Langley gained a unique behind-the-scenes look at managed care during the AMCP Partnership Forum on Closing the Gap in Real-World Evidence Use: A Collaborative Approach for Health Care Transformation.
On November 12, more than 50 managed care professionals and various health care stakeholders gathered in Old Town Alexandria, Virginia to examine these barriers to adoption for RWE in managed care.
In today’s complex health care landscape, data-driven insights are key to better decision-making. AMCP’s 2024 Access, Affordability, and Outcomes (AAO) report highlights how managed care strategies improve patient care and reduce costs. From employer-covered insurance to the benefits of 90-day medication supplies, the report offers actionable data on affordability, adherence, and savings. Explore the full report to see how AMCP supports better, more affordable care.
On Dec. 12, 2024, the Centers for Medicare and Medicaid Services (CMS) issued a final rule titled, “Modifications of Health Insurance Portability and Accountability Act of 1996 (HIPAA) National Council for Prescription Drug Programs (NCPDP) Retail Pharmacy Standards; and Modification of the Medicaid Pharmacy Subrogation Standard” (Final Rule).
The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide feedback on the “Medicare $2 Drug List Model” issued by CMS.
